High Vista Strategies LLC Invitae Corp Transaction History

High Vista Strategies LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.13 - $9.01 $160,755 - $680,002	-75,472 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$6.28 - $15.59 $191,571 - $475,572	30,505 Added 67.84%	75,472 $602,000
Q3 2021 Nov 15, 2021	BUY	$24.31 - $33.6 $439,938 - $608,059	18,097 Added 67.35%	44,967 $1.28 Million
Q2 2021 Aug 16, 2021	BUY	$26.09 - $40.4 $282,580 - $437,572	10,831 Added 67.53%	26,870 $906,000
Q1 2021 May 17, 2021	BUY	$33.06 - $56.93 $20,695 - $35,638	626 Added 4.06%	16,039 $613,000

Q3 2020 Nov 16, 2020	BUY	$28.43 - $44.67 $438,191 - $688,498	15,413 New	15,413 $668,000

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on High Vista Strategies LLC with notifications on news.